Kamimura, Hisashi
Matsuoka, Takahiro
Okai, Hiroshi
Shimizu, Naoki
Harada, Shu
Matsuo, Koji
Funding for this research was provided by:
JSPS KAKENHI (20K07977, 20H03605)
Article History
Received: 9 August 2022
Accepted: 13 October 2022
First Online: 17 October 2022
Competing interests
: TM has received speaker’s honoraria from Otsuka Pharmaceutical, Janssen Pharma, Eli Lilly, Pfizer, Meiji Seika Pharma, and Shionogi, as well as research donations from Novartis and Mitsubishi Tanabe Pharma. KM has received honoraria from Kyowa Yakuhin Kogyo, Yoshitomiyakuhin, Viatris, Janssen Pharma, Otsuka Pharmaceutical, Sumitomo Pharma, Mochida Pharmaceutical, and Eisai, and research donations from Eisai and Shionogi. All authors declare no conflicts of interest in relation to this study.